by Dr Ken Gillman | Last updated Aug 15, 2021 | Published on Aug 2, 2020 | Bias in Science
BIAS IN SCIENCE MENU 1. Understanding Science: Science and Scientific Information 2. Medical science publishing: A slow-motion train wreck 3. Guidelines: problems aplenty 4. Lancet ‘21 antidepressants’ meta-analysis 5. Stepped trials: Magnifying methodological muddles...
by Dr Ken Gillman | Last updated Aug 15, 2021 | Published on Mar 1, 2020 | Bias in Science
BIAS IN SCIENCE MENU 1. Understanding Science: Science and Scientific Information 2. Medical science publishing: A slow-motion train wreck 3. Guidelines: problems aplenty 4. Lancet ‘21 antidepressants’ meta-analysis 5. Stepped trials: Magnifying methodological muddles...
by Dr Ken Gillman | Last updated Oct 17, 2021 | Published on Jun 12, 2019 | Bias in Science, Recent Commentaries
Search for: Recent Commentaries Menu International MAOI expert group: Editorial and recommendationsStepped trials: Magnifying methodological muddles — the supernatant effectThe risk of harm from acute tyramine-induced hypertension: how significant?Advising patients...
by Dr Ken Gillman | Last updated Sep 28, 2020 | Published on Nov 22, 2018 | Bias in Science
BIAS IN SCIENCE MENU 1. Understanding Science: Science and Scientific Information 2. Medical science publishing: A slow-motion train wreck 3. Guidelines: problems aplenty 4. Lancet ‘21 antidepressants’ meta-analysis 5. Stepped trials: Magnifying methodological muddles...
by Dr Ken Gillman | Last updated Sep 28, 2020 | Published on Feb 26, 2018 | Bias in Science, Other
Bias in Science1. Understanding Science: Science and Scientific Information 2. Medical science publishing: A slow-motion train wreck 3. Guidelines: problems aplenty 4. Lancet ‘21 antidepressants’ meta-analysis 5. Stepped trials: Magnifying methodological muddles — the...
by Dr Ken Gillman | Last updated Apr 25, 2021 | Published on Aug 30, 2017 | Bias in Science
BIAS IN SCIENCE MENU 1. Understanding Science: Science and Scientific Information 2. Medical science publishing: A slow-motion train wreck 3. Guidelines: problems aplenty 4. Lancet ‘21 antidepressants’ meta-analysis 5. Stepped trials: Magnifying methodological muddles...
